The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
